West Pharmaceutical Services Inc (WST) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
West Pharmaceutical Services Inc   (NYSE: WST)

Select the Financial Report: Select the Period:


Description of West Pharmaceutical Services Inc's Business Segments


West Pharmaceutical Services Inc. operates primarily through two reportable segments: Contract-Manufactured Products and Proprietary Products. These segments encompass a diverse array of products and services specifically designed to address the needs of the pharmaceutical, diagnostic, and medical device industries. Below is an extensive breakdown of each segment along with their offerings.

Contract-Manufactured Products Segment

The Contract-Manufactured Products segment has evolved from the contract manufacturing aspect of the former Delivery Systems segment. It is a fully integrated operation that specializes in the design, production, and automated assembly of complex devices mainly for pharmaceutical, diagnostic, and medical device customers.

Offerings

1. Custom Contract Manufacturing:
- This service provides personalized manufacturing solutions tailored to meet specific customer requirements. Utilizing advanced technologies, the company applies various sophisticated manufacturing techniques, including:
- Multi-component Molding: This method allows for the creation of intricate parts using multiple materials, enhancing their functionality and overall performance.
- In-Mold Labeling: A process that simultaneously integrates product labeling within the mold, ensuring product durability and an appealing appearance.
- Ultrasonic Welding: This technology employs high-frequency sound waves to create strong, lasting joints between materials without the need for additional adhesives.
- Clean Room Molding and Device Assembly: Managed environments that guarantee that the manufactured devices satisfy the highest cleanliness and sterility standards are essential for medical applications.

2. Manufactured Components and Devices:
- The segment produces a wide range of components for various applications including:
- Surgical Devices: Tools and instruments designed for use in surgical procedures, including scalpels, forceps, and sutures.
- Diagnostic Equipment: Devices that assist healthcare professionals in detecting and analyzing medical conditions, such as blood testing tools and imaging systems.
- Ophthalmic Devices: Instruments specific to eye care, ranging from surgical implements to diagnostic devices like tonometers and lensometers.
- Injectable Drug Delivery Systems: Components designed for the safe and effective administration of medications via injection, including syringes, vials, and adaptors.
- Consumer Products: A selection of items designed for end-users, often connected with healthcare applications, such as home testing kits.

3. Expertise in Product Development:
- West takes pride in its comprehensive capabilities in product design and development:
- In-House Mold Design: Crafting molds tailored to particular product specifications ensures efficient and effective production processes.
- Engineering Center: A dedicated area for developing and testing prototypes, which facilitates thorough evaluation and refinement before moving to mass production.
- Process Design and Validation: A rigorous approach ensures that all manufacturing processes adhere to stringent quality standards.
- Automated Assembly: Utilizing high-speed assembly lines helps increase efficiency while minimizing human error during the production stages.

4. Geographical Reach:
- The Contract-Manufactured Products segment has manufacturing capabilities in North America and Europe, enabling West to offer a broad range of services and logistical efficiencies to its global clients.

Proprietary Products Segment

The Proprietary Products segment has emerged by combining aspects of the previous Packaging Systems segment with proprietary products from the Delivery Systems segment. This segment is primarily focused on developing innovative strategies within commercial operations, particularly targeting biologics, generics, and pharmaceutical drug markets.

Offerings

1. Proprietary Packaging and Containment:
- A robust selection of products designed to ensure the safety and efficacy of drug packaging, featuring:
- Stoppers and Seals: Essential components for injectable packaging systems that ensure compatibility with various drug types and optimize operational efficiency.
- Syringes and Cartridges: Critical for injectable drug applications, West offers different solutions tailored to various physical and chemical properties of the medications.

2. Self-Injectable Systems:
- Innovating self-injection systems that provide ease of use for patients, enhancing their experience and adherence to prescribed medication regimens. These systems may be compatible with connected health technologies to aid patient compliance.

3. Innovative Technologies:
- NovaPure® Product Line: This premium suite focuses on components for pre-filled delivery systems, incorporating designs like the 1-3ml NovaPure plunger, which minimizes particulate contamination and enhances reliability.
- SmartDose® Technology Platform: A platform that has gained prominence with FDA approval for a combination product in 2016. This technology allows for controlled delivery of more viscous drugs, featuring user-friendly characteristics such as programmable options and a single-button operation.

4. Drug Containment Solutions:
- Advanced containment solutions are critical for addressing compatibility challenges with traditional glass containers. West offers products such as CZ vials, syringes, and cartridges that are designed for enhanced safety, cold storage resistance, and reduced risk of breakage.

5. Analytical Lab Services:
- The Proprietary Products segment includes specialized testing and analytical services that ensure rigorous evaluation of drug packaging, devices, and administration systems to meet quality and regulatory standards comprehensively.

Conclusion

West Pharmaceutical Services Inc. showcases a comprehensive suite of products and services across its Contract-Manufactured and Proprietary Products segments. With a strong emphasis on innovation, quality assurance, and customized solutions, West is a significant contributor to healthcare packaging, delivery, and manufacturing sectors. The company’s adaptability and commitment to advancing pharmaceutical and medical device technologies illustrate its capability to meet the evolving demands of its clients within a complex healthcare landscape.


Composition of West Pharmaceutical Services Inc Revenues by Segments

 
Proprietary Products    162.43 % of total Revenue
West Vantage    34.43 % of total Revenue

Q2 three months ended (Jun 30 2026)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
Proprietary Products 1,416.90 162.43 %
West Vantage 300.30 34.43 %
Total 872.30 100 %




Q2 three months ended (Jun 30 2026)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
Proprietary Products 128.61 % 104.08 %
West Vantage - 99.4 %
Total 13.89 % 3.3 %




Q2 three months ended (Jun 30 2026)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Proprietary Products 401.10 28.31 %
West Vantage 28.50 9.49 %
Total 154.00 17.65 %




Q2 three months ended (Jun 30 2026)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Proprietary Products - -
West Vantage - -
Total 16.84 % 10.95 %




Annual Report on West Pharmaceutical Services Inc Divisions, Sales by Country

 
Proprietary Products   Proprietary Products Segment contribution to total sales 81.07 % of total Revenue
Contract-Manufactured Products   Contract-Manufactured Products Segment contribution to total sales 18.93 % of total Revenue
United States   United States Segment contribution to total sales 43.25 % of total Revenue
Germany   Germany Segment contribution to total sales 12.37 % of total Revenue
Ireland   Ireland Segment contribution to total sales 10.84 % of total Revenue
France   France Segment contribution to total sales 7.37 % of total Revenue
Other European countries   Other European countries Segment contribution to total sales 14.67 % of total Revenue
Other   Other Segment contribution to total sales 11.49 % of total Revenue


Twelve months ended 2025
WST s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
Proprietary Products 2,492.10 81.07 %
Total 3,074.00 100 %
Contract-Manufactured Products 582.00 18.93 %
United States 1,329.60 43.25 %
Germany 380.30 12.37 %
Ireland 333.30 10.84 %
France 226.60 7.37 %
Other European countries 451.00 14.67 %
Other 353.30 11.49 %


Twelve months ended 2025
WST s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total 493.70 16.06 %

Twelve months ended 2025
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
Proprietary Products 6.75 % -
Total 6.27 % 0.2 %
Contract-Manufactured Products 4.17 % -
United States 8.03 % -
Germany 2.09 % -
Ireland 3.13 % -
France -6.44 % -
Other European countries 16.99 % -
Other 4.22 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.